Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker-guided oral corticosteroid management for severe asthma
ACTRN12616001015437Phase 4Completed
- Sponsor
- Hunter New England Health
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prednisone, sponsored by Hunter New England Health. Started Jan 2017; status: completed.
02
Drugs
prednisone
Beyond the preview
Go deeper on ACTRN12616001015437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001015437.